Publication
Characterization of six clinical drugs and dietary intervention in the non-obese CDAA-HFD mouse model of MASH and progressive fibrosis
American Journal of Physiology Gastrointestestinal Liver Physiolology [online ahead of print]. Nielsen MH, Nøhr-Meldgaard J, Bonde Møllerhøj M, Oró D, Pors S, Worm Andersen M, Kamzolas I, Petsalaki E, Vacca M, Mørch Harder L, Perfield JW, Veidal S, Hansen HH, Feigh M.
MouseCDAA-HFD mouseAcetyl-CoA carboxylaseBody weightBlood biochemistryBioinformaticsMetabolic dysfunction-associated steatohepatitisFXRElafibranorGLP-1 receptorFirsocostatHistopathology scoreImage analysisImmunohistochemistry (IHC)Liver biopsyLiver morphometryNext-generation sequencingPPARLanifibranorTHR-ß receptorRNA sequencingObeticholic acidResmetiromSemaglutide
Share this page
Related resources
For further information
Contact us
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm
Denmark
+45 3152 2650